Epigenetic profiling of prostate adenocarcinoma and neuroendocrine prostate cancer models to understand EZH2 activity. [Cut & Run]
EZH2 has differential activity in prostate adenocarcinoma and neuroendocrine prostate cancer. Overall design: Epigenetic profiling was performed in prostate cancer models upon EZH2 inhibiton or silencing.